The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alpha Tau Medical LTD.
University of Massachusetts, Worcester
H. Lee Moffitt Cancer Center and Research Institute
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Centre Leon Berard
Memorial Sloan Kettering Cancer Center
Unidade Local de Saúde São João
Ohio State University Comprehensive Cancer Center
University Hospital Southampton NHS Foundation Trust
Chinese University of Hong Kong
EBG MedAustron GmbH
EBG MedAustron GmbH
Dana-Farber Cancer Institute
Varian, a Siemens Healthineers Company
Zhejiang University
Ankara Etlik City Hospital
Ohio State University
Dana-Farber Cancer Institute
University of California, Irvine
Cedars-Sinai Medical Center
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Peking Union Medical College Hospital
H. Lee Moffitt Cancer Center and Research Institute
IRCCS San Raffaele
HistoSonics, Inc.
M.D. Anderson Cancer Center
Baptist Health South Florida
RenJi Hospital
RenJi Hospital
University of Kentucky
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
University of Washington
Minia University
M.D. Anderson Cancer Center
University of Aarhus
Dana-Farber Cancer Institute
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
Insel Gruppe AG, University Hospital Bern
British Columbia Cancer Agency
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud